SARS CoV 2 News and Research

RSS

Link between COVID-19 severity and microbiome of saliva and nasopharynx

In a recent study posted to the bioRxiv* preprint server, researchers profiled the salivary and nasopharyngeal microbiomes of coronavirus disease 2019 (COVID-19) patients and determined the association between the microbiomes and COVID-19 severity.

6 Jun 2022

Safety and efficacy of SCB-2019 COVID vaccine candidate as a ChAdOx1-S booster

In a recent study posted to the medRxiv* pre-print server, researchers evaluated the immunogenicity of booster doses of alum-adjuvanted SCB-2019 vaccine candidate's three formulations.

6 Jun 2022

COVID-19's economic impact on healthcare systems, societies, and the population

In a recent study review posted to the medRxiv* preprint server, researchers evaluated the economic and medical costs incurred due to the coronavirus disease 2019 (COVID-19) pandemic.

6 Jun 2022

CRISPR-based diagnostics for SARS-CoV-2 detection

In a recent study posted to the Journal of Biochemical and Molecular Toxicology, researchers reviewed clustered regularly interspaced short palindromic repeats (CRISPR)-based diagnostics for detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

6 Jun 2022

Trial of peptide-centered SARS-CoV-2 T-cell activator in B-cell deficient individuals

A recent phase 1/2 study under review at the Nature Portfolio journal and posted to the Research Square* preprint server demonstrated that a peptide-centered severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) T-cell activator, CoVac-1, was efficient in B-cell deficient people.

6 Jun 2022

Researchers receive grant to develop portable biosensors for detecting noroviruses, mycotoxins in foods

An international team led by a University of Massachusetts Amherst food and environmental virologist has received a $750,000 USDA National Institute of Food and Agriculture (NIFA) partnership grant to develop and test portable, rapid biosensors capable of detecting noroviruses and mycotoxins in foods and agricultural products.

3 Jun 2022

Lack of diversity in genomic research could deprive Africans of life-changing care for chronic diseases

The lack of diversity in genomic research could mean Africans are missing out on potential life-changing care for chronic health disorders, according to a new study published in Nature Medicine.

3 Jun 2022

Researchers analyze autopsy findings and comorbidities associated with death caused by COVID-19

Men aged between 60 and 77 with Diffuse Alveolar Damage (DAD) –acute lung injury– in proliferative phase.

3 Jun 2022

Vaccine effectiveness against SARS-CoV-2 reinfection during periods with different dominant SARS-CoV-2 variants

A new study found that despite a lower COVID-19 vaccine efficacy against reinfection with the Omicron variant, these vaccines demonstrate a marked efficacy against reinfection with SARS-CoV-2 Alpha and Delta variants, as well as the Omicron variant.

3 Jun 2022

The effect of BNT162b2 mRNA COVID-19 vaccine on human semen

Scientists from Italy have recently analyzed the effect of the mRNA-based COVID-19 vaccine on the semen quality of adult men.

3 Jun 2022

Vaccination lowers the risk of experiencing severe COVID-19 in dialysis patients

In an analysis of patients with kidney failure receiving dialysis who had become infected with SARS-CoV-2, those who were vaccinated had a lower risk of experiencing severe COVID-19.

3 Jun 2022

A system for detecting emerging SARS-CoV-2 variants

An article published in the journal Nature Medicine examines the unpredictable evolution of the ongoing COVID-19 pandemic.

2 Jun 2022

COVID-19 superspreader events typically originate from few carriers

A recent research paper published in the journal Physics of Fluids analyzed the overdispersion in the coronavirus disease 2019 (COVID-19) airborne transmission.

2 Jun 2022

Immune modulator drugs improved clinical status, reduced deaths among patients hospitalized with COVID-19

A large randomized, placebo-controlled clinical trial led by the National Institutes of Health shows that treating adults hospitalized with COVID-19 with infliximab or abatacept - drugs widely used to treat certain autoimmune diseases - did not significantly shorten time to recovery but did substantially improve clinical status and reduce deaths.

2 Jun 2022

COVID-19 cases and outbreaks among students after their return to university in September 2020

Researchers evaluated the increase in SARS-CoV-2 infections among university students immediately after returning to their university in September 2020.

2 Jun 2022

Two cases of MIS-C after laboratory-confirmed SARS-CoV-2 breakthrough infections in fully vaccinated adolescent patients

Researchers investigated whether COVID-19 vaccination effectively protected adolescents in the United States from multisystem inflammatory syndrome (MIS).

2 Jun 2022

The effect of corticosteroids on mortality in hospitalized COVID-19 patients

Researchers assessed the impact of modern causal inference methods in estimating the effect of corticosteroids against COVID-19-related mortality.

2 Jun 2022

The effectiveness of nirmatrelvir therapy for preventing mortality and hospitalizations due to COVID-19 in high-risk patients during the Omicron surge

Researchers evaluated how effective nirmatrelvir is in preventing COVID-19-associated death and hospitalization in high-risk patients.

2 Jun 2022

The effects of accessory protein mutations and other non-spike mutations on SARS-CoV-2 pathogenesis

Researchers looked into the role played by the accessory proteins using synthetic genomics assembly technology

2 Jun 2022

New discovery could lead to highly effective ways to treat influenza

It happens every year, especially in winter. A virus saunters into your wide-open respiratory tract, worms its way into lung cells, and, next thing you know, you're lying in bed with a fever, aches, and chills-;classic symptoms of influenza, or flu.

1 Jun 2022

SARS CoV 2 News and Research

Link between COVID-19 severity and microbiome of saliva and nasopharynx

Safety and efficacy of SCB-2019 COVID vaccine candidate as a ChAdOx1-S booster

COVID-19's economic impact on healthcare systems, societies, and the population

CRISPR-based diagnostics for SARS-CoV-2 detection

Trial of peptide-centered SARS-CoV-2 T-cell activator in B-cell deficient individuals

Researchers receive grant to develop portable biosensors for detecting noroviruses, mycotoxins in foods

Lack of diversity in genomic research could deprive Africans of life-changing care for chronic diseases

Researchers analyze autopsy findings and comorbidities associated with death caused by COVID-19

Vaccine effectiveness against SARS-CoV-2 reinfection during periods with different dominant SARS-CoV-2 variants

The effect of BNT162b2 mRNA COVID-19 vaccine on human semen

Vaccination lowers the risk of experiencing severe COVID-19 in dialysis patients

A system for detecting emerging SARS-CoV-2 variants

COVID-19 superspreader events typically originate from few carriers

Immune modulator drugs improved clinical status, reduced deaths among patients hospitalized with COVID-19

COVID-19 cases and outbreaks among students after their return to university in September 2020

Two cases of MIS-C after laboratory-confirmed SARS-CoV-2 breakthrough infections in fully vaccinated adolescent patients

The effect of corticosteroids on mortality in hospitalized COVID-19 patients

The effectiveness of nirmatrelvir therapy for preventing mortality and hospitalizations due to COVID-19 in high-risk patients during the Omicron surge

The effects of accessory protein mutations and other non-spike mutations on SARS-CoV-2 pathogenesis

New discovery could lead to highly effective ways to treat influenza

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News